SUBLEASESublease • March 15th, 2022 • Biotech Acquisition Co • Pharmaceutical preparations
THIS SUBLEASE (this “Sublease”) is dated for reference purposes as of October 1, 2019, and is made by and between Blade Therapeutics, Inc., a Delaware corporation (“Sublessor”), and Applied Molecular Transport Inc., a Delaware corporation (“Sublessee”). Sublessor and Sublessee hereby agree as follows:
SUMMARY OF BASIC LEASE INFORMATIONLease • March 15th, 2022 • Biotech Acquisition Co • Pharmaceutical preparations • California
FIRST AMENDMENT TO LEASELease • March 15th, 2022 • Biotech Acquisition Co • Pharmaceutical preparations
This FIRST AMENDMENT TO LEASE (“First Amendment”) is made and entered into as of October 15, 2021, by and between BAYSIDE ACQUISITION, LLC, a Delaware limited liability company (“Landlord”), and BLADE THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
